EcoDrugPlus

Adrenoceptor Alpha 2a

Ensembl ID : ENSOPRG00000013586
Gene Symbol: ADRA2A
1 Cross references
230 Possible Orthologues:

Advanced Glycosylation End-Product Specific Receptor

Ensembl ID : ENSOPRG00000004383
Gene Symbol: AGER
1 Cross references
169 Possible Orthologues:

Alcohol Dehydrogenase 5 (Class Iii), Chi Polypeptide

Ensembl ID : ENSOPRG00000008397
Gene Symbol: ADH5
1 Cross references
400 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSOPRG00000002793
Gene Symbol: AKR1B1
3 Cross references
429 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSOPRG00000012075
Gene Symbol: AOC1
1 Cross references
230 Possible Orthologues:

Amyloid P Component, Serum

Ensembl ID : ENSOPRG00000008348
Gene Symbol: APCS
1 Cross references
440 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSOPRG00000005962
Gene Symbol: APP
1 Cross references
276 Possible Orthologues:

Angiotensin I Converting Enzyme

Ensembl ID : ENSOPRG00000014791
Gene Symbol: ACE
1 Cross references
93 Possible Orthologues:

Aph-1 Homolog A, Gamma-Secretase Subunit

Ensembl ID : ENSOPRG00000010094
Gene Symbol: APH1A
1 Cross references
137 Possible Orthologues:

Aph-1 Homolog B, Gamma-Secretase Subunit

Ensembl ID : ENSOPRG00000001020
Gene Symbol: APH1B
1 Cross references
191 Possible Orthologues:

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSOPRG00000014029
Gene Symbol: APEX1
1 Cross references
212 Possible Orthologues:

Arachidonate 12-Lipoxygenase, 12s Type

Ensembl ID : ENSOPRG00000001858
Gene Symbol: ALOX12
3 Cross references
200 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).